About Us LMPG Guidelines NACB Home Page
Top Nav Bar
Nav Bar
About NACB
Board of Directors

Membership Services
LMPG Guidelines
Meetings and Conferences
NACB Newsletter
Historical Archive


NACB publications are available through AACC Press. To make a purchase or request a catalog, contact AACC Customer Service at 202-857-0717 or by email or use the AACC online catalog at http://www.aaccdirect.org. Some Laboratory Medicine Practice Guidelines are available free on the NACB web page at http://www.nacb.org/lmpg/main.stm.


Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
Edited by Laurence M. Demers and Carole A. Spencer

Clinicians need laboratory tests of thyroid function whenever there is suspected thyroid disease. This monograph represents an updated version of previously published guidelines on thyroid function testing and discusses common thyroid problems, pre-analytic issues, and offers recommendations on the clinical utility, methodology, and performance goals of select thyroid function tests including tests of thyroid autoimmune disease. The monograph also makes recommendations on how the clinical biochemist can collaborate effectively with clinicians to improve the selection and use of thyroid tests for patient care. 2003, 128 pages, softcover, $20, Product #2130

Practice Guidelines and Recommendations for Use of Tumor Markers in the Clinic
Edited by Martin Fleisher, Ann M. nistrian, Catharine M. Sturgeon, Rolf Lamerz, and James L. Wittliff

This monograph reviews consensus recommendations of the National Academy of Clinical Biochemistry (NACB) in the United States and the European Group on Tumor Markers (EGTM) in Europe and focuses on the appropriate use of tumor markers for specific cancers such as breast, gynecological, prostate, colorectal, neuroendocrine, germ cell, B-cell dyscrasia (monoclonal gammopathies) and lung cancer. This is an excellent guide for laboratorians, clinicians, or students who want or need a comprehensive review on circulating tumor markers associated with cancer. Although the monograph is clinically oriented toward the use of tumor markers it also contains a superb review of preanalytical, analytical, and postanalytical considerations that relate to the important aspects of tumor marker measurement and quality assessment of laboratory data. This monograph should be required reading for medical students, clinical chemists, clinicians, and oncologists. 2003, 56 pages, softcover, $20, Product #2131

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
David Sacks, David Bruns, David Goldstein, Noel Maclaren, Jay McDonald, and Marian Parrott

While multiple laboratory tests are used in the diagnosis and management of patients with diabetes mellitus, the quality of the scientific evidence supporting the use of these assays varies substantially. This monograph provides specific recommendations for laboratory analysis in patients with diabetes. The role of the laboratory in diagnosis and the monitoring of therapy and complications are addressed. The recommendations cover glucose (including self-monitoring and non-invasive measurement), ketones, glycated hemoglobin, genetic markers, autoimmune markers, microalbuminuria, and miscellaneous other analytes. 2002, 64 pages, softcover, $20, Product #2081

Diagnosis and Monitoring of Hepatic Injury: Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring 
Edited by D. Robert Dufour

Hepatic injury, particularly that due to viral infection, is a common problem worldwide. End-stage complications of chronic hepatic injury such as cirrhosis (the 9th leading cause of death in North America) and hepatocellular carcinoma (the 5th leading cause of cancer death world-wide) are increasing in frequency and will continue to increase over the next three decades. This monograph, developed in part in cooperation with the American Association for Liver Diseases, offers recommendations in two major areas. First, recommendations are offered to laboratories on necessary performance characteristics and reference values for chemical, virologic, and serologic tests used to recognize hepatic injury. Second, specific recommendations are provided to clinicians and laboratorians for use of tests in diagnosis and monitoring of patients with acute and chronic liver disease. The final section of the book offers recommendations on detecting cirrhosis and hepatocellular carcinoma. Over 300 references are included to provide the scientific background on which the recommendations are based.
2000, 58 pages, softcover, $20.00, Product 1174

Standards of Laboratory Practice: Recommendations for Use of Cardiac Markers in Coronary Artery Diseases
Edited by Alan H.B. Wu, Fred S. Apple, and Myron M. Warshaw 

The practice of cardiology has undergone significant changes in recent years with development of new diagnostic and therapeutic modalities. Cardiac markers continue to play a major role in the diagnosis and management of patients with acute coronary syndromes. This monograph provides recommendations on the use of cardiac markers for rule-out of coronary artery disease of emergency department patients who present with chest pain and for the diagnosis and prognosis of patients with unstable angina and acute myocardial infarction. Also included are the criteria for establishing cutoff concentrations, assay precision, and reporting turn-around-times, and recommendations for testing cardiac markers using point-of-care testing devices.
1999, 44 pages, softcover, $20.00, Product #510

Standards of Laboratory Practice: Guidelines for Therapeutic Drug Monitoring Services
Edited by Ann Warner and Thomas Annesley 

The many recommendations presented in this monograph are intended to provide clinical laboratory scientists with the necessary information to develop a clinically relevant, cost-effective therapeutic drug monitoring service. Nine classes of drugs are covered for clinical utility and indications for monitoring, performance goals, interferences, pre-analytic and analytic issues. This material represents an extensive compilation of information which has been reviewed by experts and a consensus style conference held in Atlanta in July 1997. 
1999, 110 pages, softcover, $20.00, Product 508

Standards of Laboratory Practice: Guidelines for the Evaluation & Management of the Newborn Infant
Edited by Lawrence A. Kaplan and Susan M. Tange 

The goal of all laboratory testing is to support the diagnosis and management of disease, both acute and chronic. In infants, however, the consequences of morbidity in the early days of life may be manifested years later. This monograph provides guidelines for the evaluation and management of the high-risk newborn infant, covering respiratory functions, fluid and electrolyte status, liver function and hyperbilirubinemia, and drug monitoring. It also addresses the role of the laboratory in outcome assessment of the high-risk newborn. 
1998, 84 pages, softcover,$20.00, Product 501


Connecting the Laboratory to the Electronic Medical Record: Issues and Opportunities
Edited by Jay Jones, Steven Steindel, and David Chou 

The National Academy of Clinical Biochemistry invited experts to present information on the current status and future direction of the electronic patient record (EPR). Discussions during the two-day meeting covered hardware/software issues, legal and regulatory issues, and many different examples of actual applications of the EPR. A key feature of this meeting was the active participation of audience members in discussion. The voice recording of group discussions and 18 individual presentations are included in this multi-media CD-ROM, along with the PowerPoint presentations of 16 speakers and an electronic transcript of all discussions (Word format) 
2000, CD-ROM, $39.00, Product 1176

Copyright © 2002 NACB - All Rights Reserved